News

A new study finds that sofosbuvir-based treatment in a real-life setting offered SVR rates greater than 90% in hard-to-treat HCV genotype 3 patients with advanced liver disease.

The results of a new study reveal increased risk of cardiovascular disease in adults previously hospitalized for pneumonia or sepsis.

Reports of increasing cases of antibiotic-resistant gonorrhea are on the rise and in fact, the World Health Organization has designated the infection as high priority as it poses a great public health threat.

The FDA has just announced that it has made a panel of human plasma samples available to assist in evaluation of serological tests to detect recent Zika virus infection.

A recent study suggests that Ebola virus RNA can remain in the genital tract for more than 2 years following the acute infection period.

Newly diagnosed HIV patients have several options when it comes to notifying partners, but assisted partner notification leads to the best outcomes.

Only 6 countries have gone through pandemic preparedness—here is why that should worry us.

A recent study finds that prophylaxis with antifungal agents reduces the risk of invasive fungal infection in patients with hematological disorders.

A recent study finds that the use of sofosbuvir-based direct-acting antivirals for HCV treatment was effective and well-tolerated in elderly patients.

Can increased understanding of the role of the behavioral immune system reveal ways to address issues of bias in society?

The less-costly tobacco-plant derived vaccine will be targeted for the developing world.

The recent death of an infant in Iowa who got meningitis following exposure to the herpes simplex virus serves as a grim reminder of how dangerous the virus can be for newborns.

Jason C. Gallagher, PharmD, addresses the undetermined importance of fixed antibiotic durations.

An ingestible smart pill developed by Proteus Digital Health can remind patients with chronic diseases to take their medication.

The Center for Health Security has given us a powerful tool against future biological threats.

Authors of a recent article takes a look at echinocandins, and how they present some advantages over other classes of antifungal agents.

New research on Zika, cases of swine flu infections, parallels between Zika and HIV, a new warning sign of HIV infection, and an increase in cyclospora cayetanensis infections in United States make up the top 5 articles this week.

Researchers from LSU Health New Orleans School of Public Health finds that heterosexuals at-risk for HIV would use home-based testing kits and seek treatment if they receive a positive result.

The decision date for a NDA for a new hepatitis B vaccine, Dynavax’s Heplisav-B, has been delayed, as the FDA asked for more post-marketing study information on the vaccine.

According to a report from the Centers for Disease Control and Prevention, about 1 in 12 infants born to Zika-infected mothers will have a related birth defect.

A team of researchers at Stevens Institute of Technology are working on the development of a rapid, cost-effective diagnostic test for the detection of bacterial and viral infections.

The risk of mortality is elevated in HIV-positive individuals who have detectable levels of virus 6 months after beginning antiretroviral therapy.

A new study demonstrates that the drug regimen consisting of glecaprevir plus pibrentasvir for non-cirrhotic patients with HCV genotype 1-6 is safe and effective.

State health agencies are increasingly reporting new human cases of West Nile virus; there have been more than 150 illnesses so far this season.

A year on, the United States and most of the other countries affected by the Zika virus are better prepared to prevent outbreaks and control their spread. The proof is in the data.

Florida reports first case of sexually-transmitted Zika of 2017, while funds continue to be released for new research efforts against the virus and tests to aid in rapid diagnosis.

The pneumococcal vaccine is routinely administered to babies in the United States starting at 2 months of age.

Researchers believe they have developed an effective genetic roadmap to assist in the identification and characterization of infections in the lower respiratory tract.